Solitaire-Iv: Results Of A Phase 3 Iv To Oral Trial In Adults With Community-Acquired Bacterial Pneumonia Comparing Solithromycin To Moxifloxacin

被引：0
|
作者：
File, T. M., Jr. [1 ]
Rewerska, B. [2 ]
Tanaseanu, C. M. [3 ]
Mihailovic-Vucinic, V. [4 ]
Gonong, J. R. [5 ]
Jamieson, B. D. [6 ]
Taylor, D. [6 ]
Sheets, A. [6 ]
Keedy, K. [6 ]
Oldach, D. W. [6 ]
Fernandes, P. [6 ]
机构：
[1] Summa Hlth Syst, Akron, OH USA
[2] Diamond Clin, Krakow, Poland
[3] St Pantelimon Emergency Clin Hosp, Bucharest, Romania
[4] Clin Ctr Serbia, Belgrade, Serbia
[5] Lung Ctr Philippines, Manila, Philippines
[6] Cempra Inc, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2116
引用
收藏
页数：1
相关论文
共 50 条
  • [31] LEFAMULIN EFFICACY IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) IS UNAFFECTED BY OBESITY: POOLED ANALYSIS OF THE LEFAMULIN PHASE 3 CLINICAL TRIAL PROGRAM
    File, Thomas M.
    Beegle, Scott
    Crandon, Jared
    Varon, Joseph
    Mariano, David
    Gupta, Rohit
    Rali, Parth
    Guico-Pabia, Christine
    Sandrock, Christian E.
    CHEST, 2022, 162 (04) : 307A - 308A
  • [32] EFFICACY OF LEFAMULIN VS MOXIFLOXACIN IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: RESULTS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS
    Sandrock, Christian
    Schranz, Jennifer
    Goldberg, Lisa
    Alexander, Elizabeth
    Moran, Gregory
    Shorr, Andrew
    Gelone, Steven
    CHEST, 2019, 156 (04) : 418A - 419A
  • [33] Inpatient treatment of community-acquired pneumonia with one dose of IV therapy prior to switch to oral therapy.
    Siegel, RE
    Alicea, M
    Lee, A
    Blaiklock, R
    Schilero, GJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A845 - A845
  • [34] LATE-BREAKING ABSTRACT: Oral solithromycin has a favorable profile versus oral moxifloxacin for treatment of adult community-acquired pneumonia (CABP) in elderly patients and those with COPD or asthma
    Oldach, David
    Luna, Carlos
    Szabo, Peter
    Mitha, Ismail
    Tanaseanu, Cristina
    Doreski, Alexis
    Barrera, Carlos
    Das, Anita
    Keedy, Kara
    Jamieson, Brian
    Fernandes, Prabhavathi
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [35] SAFETY AND TOLERABILITY OF LEFAMULIN VS MOXIFLOXACIN IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: RESULTS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS
    Sandrock, Christian
    Schranz, Jennifer
    Goldberg, Lisa
    Alexander, Elizabeth
    Moran, Gregory
    Shorr, Andrew
    Gelone, Steven
    CHEST, 2019, 156 (04) : 1127A - 1128A
  • [36] Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol
    Abelenda-Alonso, Gabriela
    Rombauts, Alexander
    Gudiol, Carlota
    Meije, Yolanda
    Clemente, Mercedes
    Ortega, Lucia
    Ardanuy, Carmen
    Niubo, Jordi
    Padulles, Ariadna
    Videla, Sebastian
    Tebe, Cristian
    Carratala, Jordi
    BMJ OPEN, 2020, 10 (08): : e038957
  • [37] Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia
    Cheng, Shih-Lung
    Wu, Ren-Guang
    Chuang, Yin-Ching
    Perng, Wann-Cherng
    Tsao, Shih-Ming
    Chang, Yu-Ting
    Chang, Li-Wen
    Hsu, Ming-Chu
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (05) : 743 - 751
  • [38] Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults
    Petitpretz, P
    Arvis, P
    Marel, M
    Moita, J
    Urueta, J
    CHEST, 2001, 119 (01) : 185 - 195
  • [39] Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities
    File, Thomas M.
    Alexander, Elizabeth
    Goldberg, Lisa
    Das, Anita F.
    Sandrock, Christian
    Paukner, Susanne
    Moran, Gregory J.
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [40] Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial
    Rodriguez, George D.
    Warren, Nathan
    Yashayev, Roman
    Chitra, Surya
    Amodio-Groton, Maria
    Wright, Kelly
    FRONTIERS IN MEDICINE, 2023, 10
12345